We are live on ! Find out more

KITE

Kite Pharma, Inc.

KITE

Delisted

KITE was delisted on the 2nd of October, 2017.

62 hedge funds and large institutions have $260M invested in Kite Pharma, Inc. in 2014 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New

Increased

Maintained

Reduced

Closed

3,629% more capital invested

Capital invested by funds: $6.97M → $260M (+$253M)

1,900% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 3

1,140% more funds holding

Funds holding: 5 → 62 (+57)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders

Holders Change

+57

Holders Change %

+1,140%

% of All Funds

1.8%

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

0.03%

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	Capital Research Global Investors Los Angeles, California	+$59.1M
2	DM Deerfield Management New York	+$25M
3	Fidelity Investments Boston, Massachusetts	+$24.5M
4	JP Morgan Chase New York	+$18.6M
5	SFM Soros Fund Management New York	+$16.3M

Top Sellers

Rank	Fund	Capital Flow
1	Alyeska Investment Group Chicago, Illinois	-$1.82M
2	EA Emerald Advisers Leola, Pennsylvania	-$1.08M
3	EMFAT Emerald Mutual Fund Advisers Trust Leola, Pennsylvania	-$513K
4	Citadel Advisors Miami, Florida	-$269K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	1 Capital Research Global Investors Los Angeles, California	$65.5M	+$59.1M	+2,389,185	New
2	DM 2 Deerfield Management New York	$28.8M	+$25M	+1,011,998	New
3	3 Fidelity Investments Boston, Massachusetts	$28.3M	+$24.5M	+991,755	New
4	4 JP Morgan Chase New York	$21.4M	+$18.6M	+751,626	New
5	SFM 5 Soros Fund Management New York	$18.8M	+$16.3M	+660,148	New
6	6 Vanguard Group Malvern, Pennsylvania	$14.3M	+$12.4M	+502,820	New
7	7 Franklin Resources San Mateo, California	$10.1M	+$8.81M	+355,944	New
8	VAM 8 Visium Asset Management New York	$8.46M	+$7.35M	+297,000	New
9	AG 9 Artal Group Luxembourg	$5.99M	+$5.2M	+210,000	New
10	10 Viking Global Investors Stamford, Connecticut	$5.7M	+$4.95M	+200,000	New
11	BFA 11 BlackRock Fund Advisors San Francisco, California	$5.46M	+$4.74M	+191,707	New
12	12 Capital World Investors Los Angeles, California	$5.42M	+$4.7M	+190,000	New
13	13 Wellington Management Group Boston, Massachusetts	$3.69M	+$3.2M	+129,410	New
14	FCM 14 Frontier Capital Management Boston, Massachusetts	$3.33M	+$812K	+32,815	+39%
15	CAM 15 Cormorant Asset Management Boston, Massachusetts	$2.85M	+$2.47M	+100,000	New
16	RSCM 16 Rock Springs Capital Management Baltimore, Maryland	$2.35M	+$2.04M	+82,474	New
17	17 Jennison Associates New York	$2.22M	+$1.93M	+77,905	New
18	18 UBS AM Chicago, Illinois	$2.15M	+$1.87M	+75,600	New
19	19 State Street Boston, Massachusetts	$2.06M	+$1.78M	+72,100	New
20	BIT 20 BlackRock Institutional Trust San Francisco, California	$2.04M	+$1.77M	+71,674	New
21	SFM 21 Sphera Funds Management Tel Aviv, Israel	$1.94M	+$1.68M	+67,970	New
22	PAA 22 Peregrine Asset Advisers Portland, Oregon	$1.38M	+$1.2M	+48,490	New
23	PI 23 Putnam Investments Boston, Massachusetts	$1.33M	+$1.15M	+46,550	New
24	DFO 24 Duquesne Family Office New York	$1.14M	+$990K	+40,000	New
25	QF 25 QVT Financial New York	$1.14M	+$990K	+40,000	New

KITE Hedge Fund Activity: Q3 2014 in Review

62 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Kite Pharma, Inc. (KITE) for Q3 2014, worth a combined $260M — up 3,629% from $6.97M a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new KITE positions and 3 closed out — a net gain of 57 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $59.1M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $1.82M sold.

62 institutional investors held Kite Pharma, Inc. (KITE) as of Q3 2014, up from 5 in Q2 2014.
Funds reported $260M of Kite Pharma, Inc. stock for Q3 2014, up 3,629% quarter-over-quarter.
60 funds opened new Kite Pharma, Inc. positions in Q3 2014 and 3 closed out, a net change of +57 holders.
The largest Kite Pharma, Inc. buyer in Q3 2014 was Capital Research Global Investors, an estimated $59.1M added.
The largest Kite Pharma, Inc. seller in Q3 2014 was Alyeska Investment Group, an estimated $1.82M sold.

Based on aggregated 13F filings for Q3 2014.

Kite Pharma, Inc. KITE